Skip to content
10-Q

Quarterly Report

TIVITY HEALTH, INC.

0001564590-21-042052

← back to feed
Filed
Aug 6, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 3, 2021 49.64M sh
Shares Diluted Q2 2021 · Jun 30, 2021 50.46M sh
Shares Diluted Q2 2021 · Jun 30, 2021 50.41M sh
Shares Diluted Q2 2021 · Jun 30, 2020 48.79M sh
Shares Diluted restated Q2 2021 · Jun 30, 2020 48.83M sh
Capex Q2 2021 · Jun 30, 2021 $4.04M
Capex Q2 2021 · Jun 30, 2020 $10.36M
Operating Cash Flow Q2 2021 · Jun 30, 2021 $36.43M
Operating Cash Flow Q2 2021 · Jun 30, 2020 $130.94M
Long Term Debt Q2 2021 · Jun 30, 2021 $381.6M
Long Term Debt Q2 2021 · Dec 31, 2020 $459.25M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $24.23M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $100.39M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $60.27M
Cash And Equivalents Q2 2021 · Dec 31, 2019 $2.49M
Stockholders Equity Q2 2021 · Jun 30, 2021 $34.79M
Stockholders Equity Q2 2021 · Mar 31, 2021 $26.25M
Stockholders Equity Q2 2021 · Dec 31, 2020 $3.66M
Stockholders Equity restated Q2 2021 · Jun 30, 2020 $34.51M
Stockholders Equity restated Q2 2021 · Mar 31, 2020 $4.41M
Stockholders Equity restated Q2 2021 · Dec 31, 2019 $223.7M
Current Liabilities Q2 2021 · Jun 30, 2021 $85.47M
Current Liabilities Q2 2021 · Dec 31, 2020 $81.84M
Current Assets Q2 2021 · Jun 30, 2021 $108.9M
Current Assets Q2 2021 · Dec 31, 2020 $154.25M
Total Assets Q2 2021 · Jun 30, 2021 $523.75M
Total Assets Q2 2021 · Dec 31, 2020 $578.98M
Eps Diluted Q2 2021 · Jun 30, 2021 $0.17
Eps Diluted Q2 2021 · Jun 30, 2021 $0.55
Eps Diluted Q2 2021 · Jun 30, 2020 $0.58
Eps Diluted restated Q2 2021 · Jun 30, 2020 −$3.47
Eps Basic Q2 2021 · Jun 30, 2021 $0.17
Eps Basic Q2 2021 · Jun 30, 2021 $0.56
Eps Basic Q2 2021 · Jun 30, 2020 $0.59
Eps Basic Q2 2021 · Jun 30, 2020 −$3.49
Sga Expense Q2 2021 · Jun 30, 2021 $9.65M
Sga Expense Q2 2021 · Jun 30, 2021 $19.35M
Sga Expense restated Q2 2021 · Jun 30, 2020 $8.91M
Sga Expense restated Q2 2021 · Jun 30, 2020 $20.96M
Net Income Q2 2021 · Jun 30, 2021 $8.36M
Net Income Q2 2021 · Jun 30, 2021 $27.49M
Net Income Q2 2021 · Jun 30, 2020 $28.51M
Net Income Q2 2021 · Jun 30, 2020 −$169.6M
Operating Income Q2 2021 · Jun 30, 2021 $37.64M
Operating Income Q2 2021 · Jun 30, 2021 $74.83M
Operating Income restated Q2 2021 · Jun 30, 2020 $35.21M
Operating Income restated Q2 2021 · Jun 30, 2020 $57.89M
Revenue Q2 2021 · Jun 30, 2021 $120.07M
Revenue Q2 2021 · Jun 30, 2021 $228.16M
Revenue restated Q2 2021 · Jun 30, 2020 $81.92M
Revenue restated Q2 2021 · Jun 30, 2020 $241.62M